Antitumor Activity of Indole-3-carbinol in Breast Cancer Cells: Phenotype, Genetic Pattern, DNA Methylation Inversion

Author:

Muyzhnek E.L.1,Nikulin S.V.2,Kaprin A.D.3,Ashrafyan L.A.4,Rozhkova N.I.3,Labazanova P.G.3,Kiselev V.I.4

Affiliation:

1. Russian Scientific Center of Roentgenology and Radiology, Moscow, 117997 Russia

2. Bioclinicum Scientific Research Center, Moscow, 115088 Russia

3. P.A. Hertzen Moscow Oncology Research Center, National Medical Research Radiological Center, Moscow, 125284 Russia

4. National Medical Research Center for Obstetrics, Gynecology and Perinatology named after Academician V.I. Kulakov, Moscow, 117997 Russia

Abstract

The effect of indole-3-carbinol on a number of functions and characteristics of MDA-MB-231 breast cancer cells and MCF-10A healthy breast tissue cells has been studied. It was shown that indole-3-carbinol significantly reduced the proliferation and migration of MDA-MB-231 cells and does not affect these functions in MCF-10A cells. Incubation of MDA-MB-231 tumor cells with indole-3-carbinol (100 uM) for 48 h resulted in a marked decrease in the expression of the Wnt cascade genes, CCND1 (by 28%), SP1 (by 44%), CDK6 (by 47%), as well as EGFR (by 64%) and FASN (by 22%) genes. Incubation of MCF-10A cell line under the same conditions induced a noticeable decrease in expression of only two genes, EGFR (by 16%) and CDK6 (by 9%). In addition, indole-3-carbinol was also shown to manifest a selective DNA demethylation activity in breast tumor cells and to reverse the process of abnormal methylation and functional blockage of the anti-tumor WIF1 gene. These data indicate that drags containing indole-3-carbinol as an active component can be potential regulators of epigenetic processes in the treatment of breast cancer and other tumors. indole-3-carbinol, breast cancer, epigenetics, Wnt

Publisher

National Research Center Kurchatov Institute

Subject

Ecology,Applied Microbiology and Biotechnology,Biotechnology

Reference71 articles.

1. 1. Kaprin A.D., Starinskii V.V., Petrova G.V. The status of cancer care for the population of Russia in 2017. Moscow: P. Hertsen Moscow Oncology Research Institute, 2018. 235 p. (in Russian)

2. 2. Dobrokachestvennye zabolevaniya molochnoi zhelezy. Etio-patogenez, diagnostika, lechenie, profilaktika [Benign breast disease. Etiopathogenesis, diagnosis, treatment, prevention]. Eds A.D. Kaprin, N.I. Rozhkova. Moscow: «GEOTAR-Media» Publ., 2017, 283 p. (in Russian).

3. 3. Rasskazova E.A., Rozhkova N.I. Screening for early detection of breast cancer. Research and Practical Medicine Journal, 2014, 1(1), 45-51 (in Russian).

4. 4. Rozhkova N.I. Luchevaya diagnostika v mammologii [Radiology in mammology]. Moscow: «SIMK» Publ., 2014, 128 p. (in Russian).

5. 5. Profilaktika - prioritet klinicheskoi mammologii [Prevention is the priority of clinical mammology]. Eds N. I. Rozhkova, A. D. Kaprin. Moscow: «SIMK» Publ.; 2015, 188 p. (In Russian).

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3